Loading…
CIK 0002050709 • 3 13F filings • Feb 17, 2026 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("squadron-capital-management-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 3 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $19.6M | 8.3% | 145,000 SH | New |
| ARRIVENT BIOPHARMA INC | COM | $6.8M | 2.9%Prev: 2.0% | 338,000 SH | Increased+155,000 SH |
| AVALO THERAPEUTICS INC | COM NEW | $2.4M | 1.0% | 130,000 SH | New |
| BELITE BIO INC | SPONSORED ADS | $4.2M | 1.8% | 26,000 SH | New |
| CLIMB BIO INC | COM | $400K | 0.2% | 100,000 SH | New |
| COGENT BIOSCIENCES INC | COM | $27.7M | 11.7%Prev: 10.4% | 780,000 SH | Decreased-85,000 SH |
| COMPASS PATHWAYS PLC | SPONSORED ADS | $2.7M | 1.1%Prev: 2.7% | 388,287 SH | Decreased-216,713 SH |
| CYBIN INC | COM NEW | $4.3M | 1.8% | 525,000 SH | New |
| DBV TECHNOLOGIES S A | SPONSORED ADS | $4.6M | 1.9% | 240,000 SH | New |
| EDGEWISE THERAPEUTICS INC | COM | $8.7M | 3.7%Prev: 3.7% | 350,000 SH | Decreased+60,000 SH |
| EUPRAXIA PHARMACEUTICALS INC | COM | $3.8M | 1.6% | 500,000 SH | New |
| GH RESEARCH PLC | ORDINARY SHARES | $4.0M | 1.7% | 315,000 SH | New |
| INHIBIKASE THERAPEUTICS INC | COM NEW | $8.7M | 3.7%Prev: 1.9% | 4,225,000 SH | Increased+1,225,000 SH |
| INTELLIA THERAPEUTICS INC | COM | $728K | 0.3% | 81,000 SH | New |
| INVENTIVA SA | ADS | $1.4M | 0.6%Prev: 2.9% | 300,000 SH | Decreased-2,135,000 SH |
| KALVISTA PHARMACEUTICALS INC | COM | $11.3M | 4.8% | 700,000 SH | New |
| KODIAK SCIENCES INC | COM | $8.2M | 3.5%Prev: 6.0% | 291,710 SH | Decreased-208,290 SH |
| LIPOCINE INC NEW | COM NEW | $4.3M | 1.8%Prev: 0.6% | 530,000 SH | Increased-280,000 SH |
| MAZE THERAPEUTICS INC | COM | $20.3M | 8.6%Prev: 3.1% | 490,000 SH | Increased+155,000 SH |
| NEXTCURE INC | COM NEW | $3.4M | 1.4%Prev: 0.0% | 236,966 SH | Increased+172,502 SH |
| PALISADE BIO INC | COM | $10.6M | 4.5%Prev: 1.9% | 4,500,000 SH | Increased+1,500,000 SH |
| PASITHEA THERAPEUTICS CORP | COM NEW | $2.7M | 1.1%Prev: 0.2% | 2,100,000 SH | Increased+1,100,000 SH |
| RELMADA THERAPEUTICS INC | COM | $32.4M | 13.7%Prev: 15.8% | 6,700,000 SH | Decreased-650,000 SH |
| SPRUCE BIOSCIENCES INC | COM NEW | $6.1M | 2.6% | 70,000 SH | New |
| TARSUS PHARMACEUTICALS INC | COM | $6.6M | 2.8% | 80,000 SH | New |
| TERNS PHARMACEUTICALS INC | COM | $7.7M | 3.3% | 190,000 SH | New |
| TRAWS PHARMA INC | COM NEW | $806K | 0.3% | 713,540 SH | New |
| UPSTREAM BIO INC | COM | $6.3M | 2.7% | 230,650 SH | New |
| VENTYX BIOSCIENCES INC | COM | $3.7M | 1.6% | 410,000 SH | New |
| VERA THERAPEUTICS INC | CL A | $3.0M | 1.3% | 60,000 SH | New |
| WAVE LIFE SCIENCES LTD | SHS | $3.0M | 1.3% | 175,000 SH | New |
| XENON PHARMACEUTICALS INC | COM | $4.7M | 2.0% | 105,551 SH | New |
| ZENAS BIOPHARMA INC | COM | $1.3M | 0.6% | 36,000 SH | New |
| 13F-HR |
| 0002050709-26-000017 |
| $272.9M |
| View |